Fleischer Spencer C has engaged in a consistent pattern of reported transactions across two companies, Clorox (CLX) and Levi Strauss (LEVI), though all filings indicate no monetary value for these trades. The activity spans from December 2023 through December 2025, with a notable concentration in CLX, accounting for the majority of the 27 filings. Transactions are coded as "A," indicating acquisitions, but the absence of disclosed dollar amounts makes it impossible to determine the scale or financial significance of these moves. The filings show no sales activity, suggesting a focus solely on acquiring shares—though whether these represent open-market purchases, grants, or other forms of equity compensation remains unclear due to the lack of value disclosures.
The timing of filings appears routine, with clusters around quarterly periods—particularly at the end of calendar years—for CLX, while LEVI transactions are more sporadic. For example, four CLX filings were logged on December 31, 2025, mirroring similar year-end activity in 2024 and 2023. LEVI transactions, though less frequent, occurred intermittently, with filings in February, May, and August 2025. The absence of any sell-side activity across both stocks could imply a long-term holding strategy, but without transaction values, the broader financial context is missing. The pattern suggests administrative or scheduled equity events rather than discretionary trading, given the repetitive timing and lack of monetary detail.
AI-assisted summary